TKPHF

Takeda Pharmaceutical Company

Exchange: PINK

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

Current Price

$32.26

+0.00%

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Takeda Pharmaceutical Company (TKPHF) Quality Analysis

TKPHF GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

Run Stock X-Ray →

TKPHF Profitability

Profitability trend analysis coming soon

TKPHF Growth

Growth trend analysis coming soon

TKPHF Financial Health

Financial health indicators coming soon

TKPHF Quality & Fundamental Analysis

Takeda Pharmaceutical Company (TKPHF) is a diversified company, listed on PINK. This quality analysis page evaluates Takeda Pharmaceutical Company's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Takeda Pharmaceutical Company has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency..

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Takeda Pharmaceutical Company is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.